Accessibility Menu
Epsilon Healthcare Ltd logo

Epsilon Healthcare Ltd

(ASX) EPN

Current PriceA$0.02
Market CapA$8.56M
Since IPO (2017)-95%
5 Year-83%
1 Year-8%
1 Month-4%

Epsilon Healthcare Ltd Financials at a Glance

Market Cap

A$8.56M

Revenue (TTM)

A$12.12M

Net Income (TTM)

-A$3.09M

EPS (TTM)

-A$0.00

P/E Ratio

-6.29

Dividend

A$0.00

Beta (Volatility)

0.07 (Low)

Price

A$0.02

Volume

106,548

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.04

Estimated Earnings Date

May 14, 2026

EPN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Epsilon Healthcare Ltd

Industry

Pharmaceuticals

CEO

Peter Giannopoulos

Headquarters

Sydney, NSW 2000, AU

EPN Financials

Key Financial Metrics (TTM)

Gross Margin

22%

Operating Margin

-25%

Net Income Margin

-14%

Return on Equity

-494%

Return on Capital

-18%

Return on Assets

-7%

Earnings Yield

-15.90%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$8.56M

Shares Outstanding

389.10M

Volume

106.55K

Avg. Volume

174.68K

Financials (TTM)

Gross Profit

A$2.09M

Operating Income

-A$2.38M

EBITDA

-A$1.86M

Operating Cash Flow

-A$3.13M

Capital Expenditure

-A$169.74K

Free Cash Flow

-A$3.30M

Cash & ST Invst.

A$242.86K

Total Debt

A$10.35M

Epsilon Healthcare Ltd Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

A$5.99M

+317.7%

Gross Profit

A$1.99M

+69.9%

Gross Margin

33.14%

N/A

Market Cap

A$8.56M

N/A

Market Cap/Employee

A$611.45K

N/A

Employees

14

N/A

Net Income

A$790.36K

+209.9%

EBITDA

A$284.13K

+175.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

A$242.86K

-92.7%

Total Debt

A$10.35M

+31.0%

Accounts Receivable

A$3.63M

+257.7%

Inventory

A$1.20M

N/A

Long Term Debt

A$9.78M

N/A

Short Term Debt

A$567.88K

-92.8%

Return on Assets

-7.16%

N/A

Return on Invested Capital

-17.94%

N/A

Free Cash Flow

A$0.00

+100.0%

Operating Cash Flow

-A$285.12K

+60.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EOF.AXEcofibre Limited
A$0.02+0.00%
GTG.AXGenetic Technologies Limited
A$0.04+0.00%
CGB.AXCann Global Limited
A$0.02+0.00%
IHL.AXIncannex Healthcare Limited
A$0.04-10.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$82.87+0.07%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$36.75-0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.16+0.02%
ONDSOndas
$9.27+0.02%

Questions About EPN

What is the current price of Epsilon Healthcare Ltd?

Epsilon Healthcare Ltd is trading at A$0.02 per share.

What is the 52-week range for Epsilon Healthcare Ltd?

Over the past 52 weeks, Epsilon Healthcare Ltd has traded between A$0.02 and A$0.04.

How much debt does Epsilon Healthcare Ltd have?

As of the most recent reporting period, Epsilon Healthcare Ltd reported total debt of A$10.35M.

How much cash does Epsilon Healthcare Ltd have on hand?

Epsilon Healthcare Ltd reported A$242.86K in cash and cash equivalents in its most recent financial results.

What is Epsilon Healthcare Ltd’s dividend yield?

Epsilon Healthcare Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.